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lthough Rho regulates cytokinesis, little was
known about the functions in mitosis of Cdc42
and Rac. We recently suggested that Cdc42
works in metaphase by regulating bi-orient attachment of
spindle microtubules to kinetochores. We now conﬁrm
the role of Cdc42 by RNA interference and identify
the mechanisms for activation and down-regulation of
Cdc42. Using a pull-down assay, we found that the level
of GTP-Cdc42 elevates in metaphase, whereas the level
of GTP-Rac does not change signiﬁcantly in mitosis.
Overexpression of dominant-negative mutants of Ect2
A
 
and MgcRacGAP, a Rho GTPase guanine nucleotide
exchange factor and GTPase activating protein, respectively,
or depletion of Ect2 by RNA interference suppresses this
change of GTP-Cdc42 in mitosis. Depletion of Ect2 also
impairs microtubule attachment to kinetochores and
causes prometaphase delay and abnormal chromosomal
segregation, as does depletion of Cdc42 or expression of
the Ect2 and MgcRacGAP mutants. These results suggest
that Ect2 and MgcRacGAP regulate the activation and
function of Cdc42 in mitosis.
 
Introduction
 
During mitosis cells segregate their duplicated DNA equally to
each pole and divide into two daughter cells. The cytoskeleton
exerts different mechanical forces and governs this important
biological process. For example, at the onset of mitosis, the
instability of microtubules (MTs) increases. In prometaphase
to metaphase, MTs emanating from centrosomes bind to the
kinetochores of each sister chromatid. Once stabilized, the
bipolar attachment of MTs to chromosomes ensures that chro-
mosomes congress correctly at the metaphase plate. Sister
chromatids are then segregated to each pole in anaphase by the
combined actions of MT shrinkage and MT-associated motor
proteins (Wittmann et al., 2001). In anaphase to telophase, F-actin
and myosin accumulate in the cell cortex in the middle of the
dividing cell to form the contractile ring, which contracts and
cleaves the cell into two (Wang, 2001). Although the overall
progression through mitosis is regulated by cyclin and cyclin-
dependent kinase signaling, much remains to be learned about
the signaling mechanism that determines the aforementioned
spatio-temporal actions of the cytoskeleton.
Rho GTPases control a variety of cellular processes such
as cell adhesion, cell motility, and cell contraction through
induction of specific types of actin cytoskeleton and by local
regulation of MT dynamics (Etienne-Manneville and Hall,
2002). Although the role of Rho in induction and maintenance
of the contractile ring during cytokinesis has been well docu-
mented (Kishi et al., 1993; Mabuchi et al., 1993), the role for
other Rho GTPases in the regulation of mitotic events was,
until recently, unknown. 
 
Clostridium difficile
 
 toxin B is known
to inactivate all members of Rho GTPases by selective gluco-
sylation of the critical threonine residue (Aktories et al., 2000).
We have recently found that treatment of HeLa cells with toxin
B delays the progression of mitosis in prometaphase and that
expression of Cdc42 mutants but not those of Rac1 or RhoA
mimics this phenotype (Yasuda et al., 2004). In these cells,
spindle MTs fail to bind to chromosomes in the correct bipolar
manner, and chromosomes fail to congress at the metaphase
plate. These findings suggest that Cdc42 plays an important role
in regulating the attachment of spindle MTs to the kinetochore.
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Here, we extend this study to confirm the role of Cdc42
in mitosis by RNA interference (RNAi) and to further identify
the regulatory mechanisms for activation and down-regulation
of this Rho GTPase during cell division. Like other small GTP-
ases, Rho GTPases cycle between the GDP-bound inactive
state and the GTP-bound active state. The exchange of bound
GDP for GTP is catalyzed by guanine nucleotide exchange fac-
tors (GEFs), whereas the hydrolysis of GTP by the GTPases
is accelerated by GTPase activating proteins (GAPs; Zheng,
2001; Moon and Zheng, 2003). Previous studies showed that
activation of Rho in mitosis is regulated by the action of a
Rho exchanger, Ect2, and by the action of a Rho GAP,
MgcRacGAP.
Ect2 is a GEF for Rho GTPases, containing the hallmark
Dbl homology (DH) domain and pleckstrin homology (PH) do-
main tandem motif (Miki et al., 1993). Prokopenko et al.
(1999) showed in 
 
Drosophila melanogaster
 
 that Pebble, the
Ect2 orthologue, interacts genetically with RhoA and is re-
quired for the formation of the contractile ring and initiation of
cytokinesis. Tatsumoto et al. (1999) found in mammalian cells
that the inhibition of Ect2 function, either by overexpression of
deletion mutants lacking the DH and PH domains or by injec-
tion of anti-Ect2 antibodies, generated multinucleated cells, in-
dicating that Ect2 is involved in cytokinesis. They further
reported that Ect2, which is localized exclusively in the nu-
cleus of interphase cells, is released into the cytoplasm upon
nuclear membrane breakdown, is localized on the spindles in
metaphase, and accumulates in the cleavage furrow in telo-
phase and then in the midbody at the end of cytokinesis. Using
the pull-down assay, we previously verified the importance of
Ect2 in mitotic activation of RhoA in HeLa cells (Kimura et al.,
2000). We showed that GTP-RhoA accumulates in telophase,
and that this accumulation can be abolished by expression of
dominant-negative forms of Ect2 in synchronized HeLa cells.
Although these studies have established a role for Ect2 in Rho
activation and cytokinesis, little is known about its action on
other Rho GTPases in mitosis. Ect2 catalyzes in vitro GDP-
GTP exchange for Rac1 and Cdc42 as potently as for Rho (Tat-
sumoto et al., 1999).
MgcRacGAP is a Rho GAP conserved from 
 
Caenorhab-
ditis elegans
 
 and 
 
Drosophila
 
 to mammals (Agnel et al., 1992;
Toure et al., 1998; Jantsch-Plunger et al., 2000; Kawashima et
al., 2000). Hirose et al. (2001) expressed a catalytically inac-
tive mutant of MgcRacGAP, MgcRacGAP
 
R386A
 
, and found pro-
duction of multinucleate cells by this expression and suggested
that this GAP is required for cytokinesis. MgcRacGAP exhibits
a similar spatio-temporal localization to that of Ect2: it is
present in the nucleus of interphase cells, localizes to the spin-
dle in metaphase and anaphase, and accumulates in the midbody
at the end of cytokinesis (Hirose et al., 2001). Jantsch-Plunger
et al. (2000) found that a mutation in 
 
cyk-4
 
, a MgcRacGAP
orthologue in 
 
C. elegans,
 
 caused disassembly of the central
spindle and failure of cytokinesis. Together these results sug-
gest that MgcRacGAP/CYK-4 acts on RhoA and regulates cy-
tokinesis. However, CYK-4 stimulates GTP hydrolysis of not
only RhoA but also Rac1 and Cdc42 in vitro. Furthermore, in
vitro MgcRacGAP exhibits greater activity toward Rac1 and
Cdc42 than toward RhoA (Kawashima et al., 2000). These re-
sults raise the possibility that this molecule may also function
to regulate Cdc42 and Rac1 in mitosis.
In the present work, we have adopted a variety of strate-
gies to address the aforementioned questions. We have first
synchronized HeLa cells and performed pull-down assays for
the GTP-bound form of Cdc42 and Rac-1 to identify mitosis-
associated changes in the activation of these two GTPases. We
have examined the effects of the expression of the dominant-
negative forms of Ect2 and MgcRacGAP, or RNAi of Ect2, on
the level of GTP-bound Cdc42 and Rac1 during mitosis. We
have also investigated mitotic phenotypes of cells either sub-
jected to RNAi for Cdc42 and Ect2, or overexpressing the
aforementioned Ect2 and MgcRacGAP mutants. Our results in-
dicate that Ect2 and MgcRacGAP regulate the activation and
function of Cdc42 in mitosis.
 
Results
 
Changes in the levels of GTP-bound 
Cdc42 and Rac during mitosis
 
We used thymidine and nocodazole either alone or in combina-
tion to enrich HeLa S3 cells in G2 phase, prometaphase,
metaphase, telophase, and G1 phase, as described in Materials
and methods. To clarify the activation of Cdc42 and Rac in cell
division, we used a GST fusion of the Cdc42-Rac–interacting
binding domain (CRIB) of Pak1 (GST-CRIB-Pak; Matsuo et
al., 2002) to pull-down the GTP-bound forms of Rac1 or
Cdc42 from the lysates of these cells. We then subjected frac-
tions of the precipitates to immunoblot analysis for Cdc42 and
Rac, using antibodies specific to each GTPase. The amounts of
the GTP-bound form of each GTPase were then quantified.
GTP-bound Cdc42 accumulated to some extent during G2
phase. After nocodazole removal, the level of GTP-Cdc42 de-
creased in prometaphase, elevated transiently in metaphase,
reaching a level similar to that found for G2/G1 phases, and
then decreased again in telophase (Fig. 1 A). However, the
level of GTP-bound Rac1 did not change significantly during
mitosis (Fig. 1 A). As a reference, we also monitored the
change in GTP-Rho, which, in agreement with previous find-
ings (Kimura et al., 2000), peaked in telophase (Fig. 1 A).
 
Ect2 and MgcRacGAP regulate 
activation of Cdc42 during mitosis
 
The NH
 
2
 
-terminal fragment of Ect2 lacking the DH-PH do-
main (Ect2-N1) functions as a dominant-negative mutant and
suppresses Rho activation in telophase (Tatsumoto et al., 1999;
Kimura et al., 2000). To test if Ect2 is involved in the activa-
tion of Cdc42 in metaphase, we overexpressed this Ect2 mu-
tant in mitotic HeLa cells and performed pull-down assays
with lysates from these cells. Expression of Ect2-N1 sup-
pressed the accumulation of GTP-bound Cdc42 in metaphase
to the level found in prometaphase. As a consequence, the
level of GTP-Cdc42 remained low from prometaphase to telo-
phase in the Ect2-N1–overexpressing cells (Fig. 1 B). How-
ever, Ect2-N1 expression had no effect on the level of GTP-
bound Rac1 (Fig. 1, A and B). 
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Next, we investigated the involvement of MgcRacGAP in
the regulation of Cdc42 activation in mitosis. To this end, we
used MgcRacGAP
 
R386A
 
, a mutant that is devoid of GAP activity
and that is known to produce multinucleate cells when overex-
pressed (Hirose et al., 2001). We transfected thymidine-syn-
chronized HeLa cells with this GAP mutant and overexpressed
the mutant protein in mitotic cells. The lysates of the trans-
fected cells were then subjected to the pull-down assay. Over-
expression of MgcRacGAP
 
R386A
 
 elevated the amount of GTP-
Cdc42 in prometaphase to a level comparable to that found in
metaphase in control cells (Fig. 1 C), resulting in premature ac-
cumulation of GTP-Cdc42. Curiously, MgcRacGAP
 
R386A
 
 ex-
pression tended to suppress the Cdc42 activation thereafter (see
Discussion). In contrast, the MgcRacGAP
 
R386A
 
 expression had
little effect on the activation of Rac1 (Fig. 1 C).
We confirmed the aforementioned findings by depletion
of endogenous Ect2 with RNAi. As shown in Fig. 2 A, the
treatment of HeLa cells with RNAi for Ect2 potently sup-
pressed the expression of the endogenous protein to 
 
 
 
20% of
that found in control cells after 48 h. We then examined the
accumulation of GTP-Cdc42 in cells subjected to RNAi. Al-
though cells subjected to control RNAi exhibited an accumu-
lation of GTP-Cdc42 in metaphase, no accumulation was
found in cells subjected to Ect2 RNAi (Fig. 2 B). We also
wished to verify the role of MgcRacGAP by RNAi, but we
were unable to obtain a significant decrease of this protein by
the RNAi strategy we used for Ect2. These results suggest that
Ect2 and MgcRacGAP regulate the level of GTP-Cdc42 in mi-
tosis, the former activating Cdc42 in metaphase and the latter
suppressing Cdc42 activation in prometaphase. Interestingly,
Figure 1. Regulation of Cdc42 activation in mitosis
by Ect2 and MgcRacGAP. (A) Cell cycle–associated
changes in the level of the GTP-bound form of each
Rho GTPase. HeLa S3 cells were synchronized, col-
lected in G2 phase (lane 1), prometaphase (lane 2),
metaphase (lane 3), telophase (lane 4), and G1
phase (lane 5), respectively, and subjected to the pull-
down assay to detect GTP-Cdc42 or GTP-Rac, as
described in Materials and methods. Typical immuno-
blots are shown on the left, and the results of the
quantitative analysis are on the right. Values are
shown as means   SEM (n   4 and 3 for Cdc42 and
Rac, respectively). (B) Suppression of Cdc42 activa-
tion in metaphase by expression of a dominant-negative
mutant of Ect2. Synchronized HeLa cells were trans-
fected with pCEV32F-Ect2-N1, collected at various
phases of the cell cycle, and subjected to the pull-
down assay as described in Materials and methods.
The top diagram shows the domain structures of full-
length Ect2 and Ect2-N1 (BRCT, BRCA carboxyl terminus
domain; DH, Dbl homology domain; PH, pleckstrin
homology domain; NLS, nuclear localization signal).
The middle panel is representative of a typical exper-
iment, and the bottom panel represents the results
of quantitative analysis of three independent experi-
ments (open bars, experiments with Ect2-N1; closed
bars, the control experiment shown in A). (C) Preven-
tion of down-regulation of Cdc42 by expression of a
catalytically inactive mutant of MgcRacGAP. Synchro-
nized HeLa cells were transfected with pME18S-
MgcRacGAP
R386A, collected at various phases of the
cell cycle, and subjected to the pull-down assay as de-
scribed in Materials and methods. Top diagrams show
the structure of MgcRacGAP and MgcRacGAP
R386A
(coiled-coil, coiled-coil domain; RhoGAP, GTPase acti-
vating homology domain). The middle panel is repre-
sentative of a typical experiment, and the bottom
panel represents the results of quantitative analysis of
three independent experiments (open bars, experi-
ments with MgcRacGAP
R386A; closed bars, the control
experiment shown in A). 
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neither Ect2 nor MgcRacGAP appears to regulate Rac activa-
tion in mitosis, although they show catalytic activity toward
Rac in vitro.
 
RNAi for Cdc42 or Ect2 causes a delay 
in metaphase progression
 
We have recently suggested that Cdc42 regulates the bi-ori-
ented attachment of spindle MTs to kinetochores during
metaphase (Yasuda et al., 2004). This suggestion was based on
experimental findings using toxin B and Cdc42 mutants. Here,
we confirmed these findings by depletion of Cdc42 with RNAi,
and also by depletion of Ect2. As with RNAi for Ect2, RNAi
for Cdc42 in HeLa cells effectively suppressed expression of
the endogenous protein to 
 
 
 
10% of that found in control cells
(Fig. 2 A). Therefore, we transfected HeLa cells with the re-
spective RNAi and cultured the cells for 50 h, during which
time they were subjected to a double thymidine block to syn-
chronize the cell cycle progression. Cells were collected at dif-
ferent time points after release from the second thymidine block
and then subjected to flow-cytometry analysis. We found that
whereas cells subjected to control RNAi or RNAi for Cdc42 or
Ect2 progressed through S phase at comparable rates, exit from
mitosis was consistently delayed in the cells subjected to Cdc42
or Ect2 RNAi when compared with control RNAi cells; per-
centages of cells with 4N DNA content 11 h after thymidine re-
lease were 33, 32, and 33 for control, Cdc42, or Ect2 RNAi
cells, respectively; by 12 h, percentages were 26, 32, and 33;
and by 15 h, they were 18, 24, and 26. The cells were then fixed
12 h after release, and the mitotic index of each population was
determined by staining for MTs and chromosomes (Fig. 3 A).
The mitotic index of control RNAi cells was 
 
 
 
9%, whereas the
indexes for Cdc42 and Ect2 RNAi cells were significantly
higher and were 22 and 19%, respectively. Interestingly, com-
bined RNAi for Cdc42 and Ect2 together increased the mitotic
index (17.5%) to nearly the values observed with RNAi for ei-
ther alone. This lack of synergy is consistent with our hypothe-
sis that Ect2 and Cdc42 work in the same pathway. Immunoflu-
orescence analysis of mitotic cells in these populations revealed
that although the majority of cells had formed a bipolar spindle,
chromosomal congression was often impaired; in some cells,
chromosomes were widely scattered and in others some chro-
mosomes remained around either pole (Fig. 3 B). Quantitative
analysis revealed that the proportion of cells that showed
such misaligned chromosomes was significantly higher in the
Cdc42- or Ect2-depleted cell population when compared with
the control cell population (Fig. 3 C). Consequently, the pro-
portion of cells in metaphase was significantly lower in the
Cdc42- or Ect2-depleted cell populations. Staining of these
cells both for CENP-A, a kinetochore protein, and Mad2 re-
vealed the presence of Mad2 at a significant number of kineto-
chores (Fig. 3 D). Mad2 associates with the kinetochore in the
absence of spindle MT binding where it functions to arrest cell
cycle progression, thus ensuring that the cell progresses to
anaphase only when all kinetochores have attached with spindle
MTs (Cleveland et al., 2003). These results indicate the loss of
MT attachment to kinetochores in cells where either Cdc42 or
Ect2 or both of these proteins have been depleted. Interestingly,
however, significant proportions of the cells subjected to RNAi
for Ect2 or Cdc42 nonetheless progressed to anaphase and sub-
sequently to telophase. Consistently, most of these cells pro-
gressed to G1, resulting in cells with micro- and macronuclei
(Fig. 3, C and E). These results suggest that the spindle check-
point mechanism was impaired in these cell populations. Our
previous work showed that Cdc42 acts on its effector, mDia3,
which localizes to kinetochores in mitosis, and that toxin B
treatment disrupts this localization (Yasuda et al., 2004). We
wondered if depletion of Ect2 or Cdc42 has similar effects on
mDia3 localization. We found that, although the mDia3 signals
were seen as small punctate spots next to those of CENP-A in
control RNAi cells, these signals became diffuse and blurred
upon Ect2/Cdc42 depletion (Fig. 3 F).
To gain a greater insight into this process, we used video
microscopy to monitor the mitotic progression of cells sub-
jected to Ect2 or Cdc42 depletion. Whereas the control cells
Figure 2. RNAi for Ect2 and its effects on
accumulation of GTP-Cdc42 in metaphase. (A)
Depletion of Cdc42 or Ect2 by RNAi. HeLa
cells were subjected to RNAi for Ect2 (Ect2
RNAi), Cdc42 (Cdc42 RNAi), or E. coli LacZ
(control RNAi). After 24 and 48 h, the cells
were lysed and subjected to immunoblot with
the respective antibody. (B) Effects of Ect2
depletion on accumulation of GTP-Cdc42 in
metaphase. HeLa S3 cells were transfected
with control or Ect2 siRNA after the first thymi-
dine block. The cells then underwent a second
thymidine block and, after release from this
block, were collected at different phases of the
cell cycle and subjected to the pull-down assay.
One sixth of the precipitates and one twenti-
eth of the supernatant were used to show the
amount of GTP-Cdc42 and total Cdc42, respec-
tively. The top panel represents typical immuno-
blots and the bottom represents the results of
quantitative analysis of three independent
experiments (closed bars, experiments with con-
trol RNAi; open bars, Ect2 RNAi experiment).
Values are shown as means   SEM (n   3). 
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progressed from prometaphase to telophase within 50 min
(Fig. 4 A and Video 1, available at http://www.jcb.org/cgi/
content/full/jcb.200408085/DC1), chromosomes in cells sub-
jected to Ect2 RNAi took longer to assemble at the metaphase
plate, and this assembly was never quite complete. In many
cells, some chromosomes remained adjacent to either pole,
whereas the majority appeared to assemble at the metaphase
plate (Fig. 4 B and Video 2, available at http://www.jcb.org/
cgi/content/full/jcb.200408085/DC1). A similar phenotype
was observed in cells subjected to RNAi for Cdc42 alone (Fig.
4 C and Video 3, available at http://www.jcb.org/cgi/content/
full/jcb.200408085/DC1) or both Ect2 and Cdc42 together
(not depicted). In addition, depletion of Ect2 resulted in fail-
ure of cytokinesis in 40% of the cells observed (
 
n
 
 
 
  
 
19), thus
confirming the role of Ect2 in the regulation of cytokinesis.
Together, these results confirm our previous suggestion that
Cdc42 regulates the bipolar attachment of spindle MTs to ki-
netochores before chromosome congression in metaphase and
further suggest that Ect2 regulates the activation of Cdc42
during this process.
Figure 3. Prometaphase delay by RNAi for Cdc42 or Ect2 in HeLa cells. (A) Mitotic index. Cells subjected to RNAi were synchronized in S phase by double
thymidine block, and were fixed at 12 h after release from the second block. The RNAi cells were identified by coexpression of pEGFP-histone H2Bk.
The cells were stained for MTs and chromosomes and the mitotic index was calculated by examining more than 250 cells in each of four independent
experiments. Results are the mean   SEM (n   4). *, P   0.05 versus control RNAi cells. (B) Immunofluorescence. Cells treated as in A and expressing
EGFP-H2Bk (green) were stained for chromosomes (DAPI, blue) and  -tubulin (red). Arrowheads indicate misaligned chromosomes. (C) Prometaphase delay.
Mitotic cells in each population were examined and the percentages of cells in prometaphase (cells with misaligned chromosomes), metaphase (cells with
chromosomes aligned at the metaphase plate), or ana/telophase (cells showing chromosome segregation) were determined. Results are mean   SEM (n   3).
(D) Mad2 staining. Cells treated as in A were subjected to staining for Mad2 (green), CENP-A (red), and chromosomes (DAPI, blue). Insets are enlargements
of the indicated regions of interest. (E) Production of aberrant multinucleate cells. Cells subjected to respective RNAi were fixed at 14 h after the re-
lease and stained for  -tubulin (red) and chromosomes (DAPI, blue and right column). Arrowheads show micronuclei. (F) mDia3 localization. HeLa
cells subjected to control RNAi or RNAi for Ect2 or Cdc42 were subjected to staining for mDia3 (green), CENP-A (red), and with DAPI (blue). Bars:
(B, E, and F) 10  m; (D) 2  m. 
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Expression of dominant-negative Ect2 
and MgcRacGAP mutants causes 
prometaphase delay
 
The aforementioned role of Ect2 was further confirmed by ex-
pression of the dominant-negative mutant Ect2-N1. HeLa cells
were synchronized with thymidine in early S phase and trans-
fected with Ect2-N1. The cells were released from the thymidine
block and enriched in mitosis by the use of nocodazole. The cells
were then allowed to enter and progress through mitosis upon no-
codazole removal. At 120 min after nocodazole removal, the ma-
jority of control cells expressing GFP had reached the end stage
of telophase (Fig. 5 A, a and b). When we expressed Ect2-N1 in
mitotic cells, we observed a significant increase in the number of
binucleate cells containing two nuclei of equal size (Fig. 5 A, c
and d) as reported previously (Tatsumoto et al., 1999; Kimura et
al., 2000). However, the more striking observation is the accumu-
lation of cells showing aberrant nuclei with nuclear invaginations
and micronuclei (Fig. 5 A, e and f), and also of cells arrested in
prometaphase with scattered chromosomes (Fig. 5 A, g and h).
Immunostaining revealed that Mad2 was present at some kineto-
chores of condensed chromosomes in prometaphase-arrested
cells, suggesting the absence of MT attachment to these kineto-
chores (Fig. 5 B). Quantification of the numbers of the cells
showing these phenotypes revealed statistically significant in-
creases in the number of cells showing each phenotype upon
Ect2-N1 expression compared with GFP expression (10.2 vs.
4.4% for binucleated cells, 13.2 vs. 3.3% for cells with abnormal
nuclei, and 20 vs. 9.6% for cells in prometaphase; Fig. 5 C). Ac-
cumulation in prometaphase and aberrant nuclear shape were also
noted in cells expressing CRIB-Pak, a protein motif capable of
trapping the active form of Cdc42 (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200408085/DC1).
Figure 4. Ect2 and Cdc42 depletion induce abnormalities in chromosome alignment and segregation in HeLa cells. HeLa cells were cotransfected with
pEGFP-EB1 and pDsRed2-histone H2Bk together with control siRNA (A), Ect2 siRNA (B), or Cdc42 siRNA (C) and time-lapse imaging was taken after
48 h. The bottom panels of each set show the EGFP-EB1 images only. The movies of these time-lapse acquisitions are available online as Videos 1–3
(available at http://www.jcb.org/cgi/content/full/jcb.200408085/DC1). 
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Next, we expressed MgcRacGAP
 
R386A
 
 in mitotic cells and
examined the effect of MgcRacGAP inactivation on mitosis es-
sentially in the same manner as described for Ect2-N1. Expres-
sion of MgcRacGAP
 
R386A
 
 not only induced binucleate cells con-
taining two nuclei of equal size (Fig. 6 A, a and b), as reported
previously (Hirose et al., 2001), but also caused the accumula-
tion of cells with aberrant nuclei with nuclear invaginations and
micronuclei (Fig. 6 A, c and d) and the accumulation of cells ar-
rested in prometaphase with scattered chromosomes (Fig. 6 A, e
and f). Again, immunostaining revealed that Mad2 was pres-
ent at the kinetochores of some condensed chromosomes in
prometaphase-arrested cells (Fig. 6 B). Quantification revealed
that 9.4, 6.3, and 21.6% of the MgcRacGAP
 
R386A
 
-transfected
cells were binucleate, multinucleate with aberrant shape, and ar-
rested in prometaphase, respectively (Fig. 6 C). We found that
expression of Cdc42
 
G12V
 
 resulted in the production of compara-
ble populations of cells exhibiting these three mitotic pheno-
types (Fig. 6 C). These results, together with those observed in
the pull-down assay (Fig. 1 C), have verified the participation of
MgcRacGAP in the regulation of Cdc42 in mitosis.
 
Cell cycle–associated changes in the 
spatial localization of Cdc42
 
The aforementioned results strongly suggest that Cdc42 works
spatio-temporally in the mitosis of mammalian cells. To inves-
tigate the localization of endogenous Cdc42 during the cell cy-
cle, we stained for Cdc42 in HeLa cells in different phases of
mitosis. We tested the specificity of the antibody against Cdc42
by Western blot analysis of HeLa cell lysates. This antibody
recognized a single band in HeLa cell lysates, the intensity of
which could be increased in a sample enriched in Cdc42 using
GST-CRIB-Pak beads (Fig. 7 A). The specificity of the anti-
body was further verified by Cdc42 RNAi, as the intensity of
the band recognized by this antibody decreased with depletion
of the endogenous protein (Fig. 2 A). This antibody was then
used for immunofluorescence studies to determine the localiza-
tion of endogenous Cdc42 in mitotic HeLa cells. The most
prominent feature observed using this antibody was the appear-
ance of a spindle shape signal in metaphase cells (Fig. 7 B).
Costaining for 
 
 
 
-tubulin revealed that this signal was localized
along MTs of the mitotic spindle and that the signal was more
concentrated at the minus-end region of these MTs. The addi-
tion of either the immunogenic peptide (Fig. 7 C) or recom-
binant GST-Cdc42 (not depicted) abolished this signal, sug-
gesting that it represented endogenous Cdc42. Furthermore,
staining for Rho under identical conditions did not reveal any
specific signal (unpublished data). The Cdc42 signal localized
in the spindle MTs of prometaphase cells, moved to the central
spindle as cells progressed through anaphase to telophase, and
finally concentrated in the intercellular bridge formed between
two daughter cells at the end of cytokinesis (Fig. 7 B). When
costaining for MgcRacGAP was conducted, the MgcRacGAP
Figure 5. Effects of overexpression of Ect2-N1
on mitosis of HeLa cells. (A) Mitotic phenotype.
HeLa cells synchronized in S phase were
transfected with pEGFP (a and b) or pEGFP-
Ect2-N1 (c–h). The cells were fixed 120 min
after nocodazole removal and subjected to
fluorescence microscopy for GFP (a, c, and e,
green), anti– -tubulin staining (g, green), and
DAPI (a–h, blue). The Ect2-N1-expressing cells
show the binucleate phenotype (c and d), the
multinucleate phenotype with macro- and micro-
nuclei (e and f), or the prometaphase arrest
(g and h). (B) Mad2 staining. The Ect2-N1–
expressing  cells were treated as in A and
stained for CENP-A (red), Mad2 (green), and
chromosomes (DAPI, blue). Positive Mad2
staining was detected at some kinetochores.
(C) Quantitative analysis of the mitotic pheno-
types of the cells expressing Ect2-N1. These
experiments were repeated seven times, and
the numbers of cells showing each mitotic phe-
notype were determined in more than 200
cells each experiment. Results shown are the
mean   SEM (n   7). *, P   0.05 versus each
corresponding subpopulation of the pEGFP-
transfected cells. Bars: (A) 10  m; (B) 2  m. 
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signal was also seen on spindle MTs from prometaphase to
telophase and partially colocalized with the Cdc42 signal.
However, the signals for the two molecules began to separate
in late anaphase, and, at the end of cytokinesis, the MgcRac-
GAP signal no longer overlapped with that of Cdc42; the
former concentrated in the Fleming body and the latter on the
bridge on either side of it.
To test whether or not the distribution of the Cdc42 signal
on the spindle MTs was under regulation of Ect2 and MgcRac-
GAP, we expressed dominant-negative mutants of these mole-
cules in mitotic HeLa cells and performed Cdc42 immunostain-
ing (Fig. 7 D). In the cells transfected with MgcRacGAP
 
R386A
 
,
the Cdc42 signal was observed all along the spindle MTs,
reaching the vicinity of the kinetochores, where the MgcRac-
GAP signal was also observed (Fig. 7 D; 65% of 20 transfected
cells). In contrast, when EGFP-Ect2-N1 transfection was per-
formed, the Ect2-N1 signal was distributed from the vicinity of
the kinetochores on chromosomes to the plus-end region of the
mitotic spindle, and the Cdc42 signal became more limited to
the minus-end region of the spindle in the vicinity of the cen-
trosomes (61% of 23 transfected cells).
 
Discussion
 
We recently conducted a series of experiments using toxin B
and various Rho GTPase mutants, and examined their role in
mitosis (Yasuda et al., 2004). The results of these experiments
indicate that Cdc42 acts on its downstream target, mDia3, and
facilitates bi-orient attachment and stabilization of spindle MTs
to kinetochores. Here, we have adopted several strategies to ex-
tend this study and, further, to clarify the pathway regulating
Cdc42 in mitosis. First, we used the pull-down assay for GTP-
Cdc42, and found accumulation of GTP-Cdc42 in metaphase
of HeLa S3 cells, which is consistent with the proposed action
of Cdc42 in metaphase. Second, we expressed dominant-nega-
tive forms of Ect2 and MgcRacGAP, a GEF and a GAP of Rho
GTPases in mitosis, respectively, or depleted Ect2 by RNAi,
and found that the aforementioned accumulation of Cdc42 in
metaphase was abolished by these procedures. Third, we per-
formed RNAi for Cdc42 and Ect2 or expressed the dominant-
negative mutants of Ect2 and MgcRacGAP, and found that
these procedures cause the prometaphase delay similar to that
found in the previous study. Finally, using immunofluores-
cence, we found that a subpopulation of Cdc42 is associated
with the spindle MTs and that its localization is regulated by
the activities of Ect2 and MgcRacGAP. These results strongly
argue that Ect2 and MgcRacGAP regulate the activation and
function of Cdc42 in mitosis.
Regulation of Cdc42 in mitosis by Ect2 and MgcRacGAP
is intriguing, given previous findings that the two molecules
regulate Rho in mitosis (Tatsumoto et al., 1999; Kimura et al.,
2000; Jantsch-Plunger et al., 2000; Hirose et al., 2001; Mi-
noshima et al., 2003). These results, together with our current
findings, indicate that the same GEF and GAP can regulate two
different Rho GTPases, Cdc42 and Rho, in different phases of
mitosis. Both Ect2 and MgcRacGAP are present in interphase
nuclei, are released to the cytoplasm after nuclear envelope
breakdown, associate with the spindle MTs, and change their
localization during cell division (Tatsumoto et al., 1999; Hirose
et al., 2001). These results indicate that they associate with dif-
ferent proteins in different phases of mitosis and/or are modi-
fied differently. It is tempting to think that such interactions
Figure 6. Effects of overexpression of
MgcRacGAP
R386A on mitosis of HeLa cells.
(A)  Mitotic phenotypes. HeLa cells synchro-
nized in S phase were transfected with either
pEGFP alone or pEGFP and pME18S-
MgcRacGAP
R386A (a–f). At 120 min after no-
codazole removal, the cells were fixed and
subjected to fluorescence microscopy for GFP
(a and c, green), anti– -tubulin staining e,
green), and DAPI (a–f, blue). MgcRacGAP
R386A-
expressing cells show the binucleate pheno-
type (a and b), the multinucleated phenotype
with macro- and micro-nuclei (c and d), or the
prometaphase arrest (e and f). (B) Mad2
staining.  The MgcRacGAP
R386A-expressing
cells were treated as in A and stained for
CENP-A (red), Mad2 (green), and chromo-
somes (DAPI, blue). Positive Mad2 staining
was detected at some kinetochores. (C) Quan-
titative analysis of the mitotic phenotypes of
the cells expressing MgcRacGAP
R386A. The mi-
totic phenotype of HeLa cells expressing GFP,
MgcRacGAP
R386A (MRG-R386A), or Cdc42
G12V
was examined in more than 200 cells for each
experiment, and the percentages of cells
showing prometaphase arrest, binucleate, or
aberrant multinucleate phenotypes were de-
termined. Results represent the mean   SEM
(n   7). *, P   0.05 versus each correspond-
ing subpopulation of the pEGFP-transfected
cells. Bars: (A) 10  m; (B) 2  m. 
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and/or modifications determine not only their localization but
also their specificity. For example, the NH
 
2
 
-terminal domain of
Ect2 that we used in these experiments contains the tandem
BRCT domains. It was reported recently that the tandem BRCT
domains have affinity for phospho-proteins (Yu et al., 2003).
Therefore, it is likely that the BRCT domain of Ect2 binds to
specific phosphorylated proteins, which in turn provide signals
that dictate the specificity of Ect2. Ect2 might bind to different
phospho-proteins in metaphase and telophase, which then may
provide the phase-specific specificity of this exchanger. More-
over, a subpopulation of Ect2 is phosphorylated early in mitosis
(Tatsumoto et al., 1999; Kimura et al., 2000). Experimental ev-
idence for, and an implication of such an interaction and modi-
fication, are clearer for MgcRacGAP. Recently, Ban et al.
(2004) reported that MgcRacGAP binds PRC1, a mitotic CDK
substrate, and that this binding inhibits MgcRacGAP activity
toward Cdc42 in metaphase. This finding can explain how
Cdc42 is activated in metaphase in spite of its colocalization
with MgcRacGAP on the metaphase spindle (Fig. 7 B). It is
also known that covalent modification of MgcRacGAP changes
its substrate specificity. Minoshima et al. (2003) found that
phosphorylation of MgcRacGAP by Aurora kinase B induces
latent GAP activity toward RhoA, and this activity is important
for down-regulation of Rho at the end of cytokinesis. Thus,
it appears that both Ect2 and MgcRacGAP work on Cdc42
around metaphase, whereas they act on RhoA late in mitosis. It
is intriguing that the expression of MgcRacGAP
 
R386A
 
 elevated
the level of GTP-Cdc42 in prometaphase but tended to suppress
the Cdc42 activation in metaphase. We do not have an experi-
mental explanation for the latter effect. It may be a secondary
effect due to the prometaphase arrest induced by this MgcRac-
GAP mutant. In addition, Somers and Saint (2003) found asso-
Figure 7. Localization of Cdc42 in mitotic cells. (A) Specificity of the antibody to Cdc42. One fiftieth of HeLa cell extracts from one 10-cm dish (lane
1) or one fourth of the pull-down precipitates of lysates from four dishes of HeLa cells at metaphase using the GST-CRIB-Pak (lane 2) were probed with
the monoclonal anti-Cdc42 antibody. (B) Cdc42 localization in mitotic HeLa S3 cells. Randomly growing HeLa S3 cells were preextracted for 1 min
with 0.5% Triton X-100 in PHEM, fixed, and stained for Cdc42 (green), MgcRacGAP (red), and chromosomes (DAPI, blue). Immunofluorescence im-
ages of the cells in each phase of mitosis are shown. (C) Competition experiments. The cells were treated as in B and subjected to staining for Cdc42
(red) and chromosomes (DAPI, blue) in the presence of the immunogenic peptide. A single representative cell in metaphase is shown (a, merged image;
b, staining for Cdc42 alone). (D) Effects of MgcRacGAP
R386A or Ect2-N1 expression on distribution of Cdc42 on the metaphase spindle. The cells were
cotransfected with MgcRacGAP
R386A together with EGFP (a–d) to allow the identification of transfected cells, or with EGFP-Ect2-N1 (e–h) and treated as
in B. Chromosomes were stained with DAPI (a, c, e, and g, blue). Cdc42 was stained with monoclonal anti-Cdc42 antibody and detected with goat
anti–mouse IgG coupled to Alexa-647 and pseudo-colored to green (a–d) or with donkey anti–mouse IgG coupled to Alexa-594 shown in red (e–h).
MgcRacGAP is shown in red (a–d). EGFP-Ect2-N1 is shown in green (e–h). Two different optical sections of a single cell are shown each in a and b
and c and d. Bars, 10  m. 
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ciation of a 
 
Drosophila
 
 MgcRacGAP orthologue, RacGAP50C,
with a 
 
Drosophila
 
 Ect2 orthologue, Pebble, during mitosis.
Therefore, it is possible that overexpressed MgcRacGAP
 
R386A
 
binds to endogenous Ect2 and affects its activity.
Here, we performed RNAi for Cdc42 and Ect2 and found
that depletion of either protein induces prometaphase delay,
which is essentially similar to that found in cells subjected to
toxin B treatment, overexpression of Cdc42 mutants, and RNAi
for mDia3 (Yasuda et al., 2004). Furthermore, we found that ex-
pression of MgcRacGAP
 
R386A
 
 also interfered with the transition
to metaphase in a similar way. This, although apparently para-
doxical, is consistent with our finding that both dominant-active
and dominant-negative Cdc42 mutant induced the delay in
prometaphase, and can be explained by misorientation of the
spindle MTs by ectopic expression of an excess amount of ac-
tive Cdc42. Although dominant-active and dominant-negative
Cdc42 mutants induce the opposing actin phenotypes, they
cause the same phenotype with respect to MT targeting in inter-
phase cells (Etienne-Manneville and Hall, 2001). These results
not only corroborated the role of Cdc42 in the MT attachment to
kinetochores but also that Ect2 and MgcRacGAP regulate this
Cdc42 function. In contrast, previous studies have shown that
interfering with Ect2 and MgcRaGAP causes cytokinesis fail-
ure, which led the authors to suggest that Ect2 and MgcRac-
GAP are linked mainly with RhoA (Tatsumoto et al., 1999;
Jantsch-Plunger et al., 2000; Kimura et al., 2000; Hirose et al.,
2001). However, though not explicitly described in the previous
papers, the tetraploid nucleus in these cells was abnormal in
shape. Furthermore, Van de Putte et al. (2001) reported that ho-
mozygous disruption of the gene for MgcRacGAP resulted in
death of E3.5–4 embryos due to the failure of chromosomal
segregation. In addition, expression of active forms of Pak, an
effector of Cdc42, resulted in the production of cells with multi-
ple spindles (Vadlamudi et al., 2000), and an endogenous Pak
isoform, Pak 1, was shown to localize at the kinetochore in mi-
totic cells (Li et al., 2002). Recently, Tatsumoto et al. (2003)
used 
 
Xenopus laevis 
 
mitotic extracts and examined in vitro the
effect on mitosis of anti-Ect2 antibody as well as dominant-neg-
ative forms of Ect2 and Rho GTPases. They found that addition
of either anti-Ect2 antibody or dominant-negative Ect2 or
Cdc42 interfered with normal progression of metaphase by
causing many misaligned chromosomes, a phenotype very sim-
ilar to that found in HeLa cells in this study. These results add
further support to the role of Ect2 and Cdc42 in mitosis.
Thus, our current findings indicate that Cdc42 is essential
in mitosis. Curiously, however, Chen et al. (2000) established a
Cdc42 null cell line from ES cells by disruption of the Cdc42
gene, and reported that the Cdc42-null ES cells can prolifer-
ate normally. These findings suggest a possibility that other
Cdc42-related GTPases such as TC10 and Chp may compen-
sate for the absence of Cdc42. Indeed, the mitotic phenotype in
Cdc42 RNAi cells appear milder than that found in toxin
B–treated cells. Recently, we found that RNAi for all of the
five Cdc42-related GTPases induces a more dramatic pheno-
type than that of RNAi for Cdc42 alone (unpublished data).
An interesting question is where Cdc42 is localized and
functions in mitosis. Our immunofluorescence study showed
that Cdc42 localizes on the mitotic spindle of HeLa cells during
prometaphase and metaphase and is concentrated in the central
spindle in anaphase and in the bridge MTs in the midbody at the
end of cell division. This Cdc42 localization is consistent with
the reported localization of Ect2 during cell division (Tatsu-
moto et al., 1999). Association of these molecules with spindle
MTs was also suggested by a recent proteome study of isolated
midbody preparation (Skop et al., 2004). Interestingly, Ect2-N1
accumulates in the vicinity of the kinetochores of metaphase
cells (Fig. 7 D). Ect2 may generate GTP-bound Cdc42 around
the kinetochores of metaphase chromosomes. Together, our
results provide evidence that Ect2 and MgcRacGAP regulate
the activation and function of Cdc42 spatio-temporally in mito-
sis, the former catalyzing the guanine nucleotide exchange of
Cdc42 to activate Cdc42 in metaphase, and the latter facilitating
the GTP hydrolysis of Cdc42 in prometaphase.
 
Materials and methods
 
Materials
 
Rabbit polyclonal antibody, P-1 to Cdc42 and C-20 to Ect2, and mouse
mAb, B-8 to Cdc42 and 26C4 to RhoA, were purchased from Santa Cruz
Biotechnology, Inc. Mouse mAb 05–389 to Rac1 and Tub 2.1 to 
 
 
 
-tubulin
were purchased from Upstate Biotechnology and Sigma-Aldrich, respec-
tively. CREST serum recognizing CENP-A was provided by T. Mimori (Ky-
oto University, Kyoto, Japan). Polyclonal antibody to MgcRacGAP and
cDNA for MgcRacGAP
 
R386A
 
 were reported previously (Hirose et al.,
2001). All other materials used were of reagent grade.
 
Plasmids, siRNA preparation, and transfection
 
pGEX4T1-CRIB-Pak has been described previously (Matsuo et al., 2002).
Ect2 cDNA was provided by T. Miki (National Institutes of Health, Be-
thesda, MD). pCEV32F-Ect2-N1 has been described previously (Kimura et
al., 2000). pEGFP-Ect2-N1 was generated by digestion of pCEV32F-Ect2-
N1 with BamHI and EcoRI and inserted into BglII–EcoRI–digested pEGFP-
C1. pEGFP-EB1, pEGFP-histone H2Bk, pEGFP-Cdc42
 
G12V, and pDsRed2-
histone H2Bk have been described previously (Yasuda et al., 2004).
To generate siRNA against Ect2 and Cdc42, we used the BLOCK-iT
RNAi-TOPO Transcription and the BLOCK-iT Dicer RNAi kits (Invitrogen).
In brief, the NH2-terminal 1,000 nucleotides of Ect2, starting from the first
methionine, were amplified by PCR using the primers ATGGCTGAAAAT-
AGTGTATTAACATCCACT and ATTTCTTGAGCTCAGGAGTATTTGCC-
TTTT. The full coding sequence of Cdc42 (G25K, Homo sapiens) was am-
plified by using the primers ATGCAGACAATTAAGTGTGTTGTTGTG-
GGCGA and TCATAGCAGCACACACCTGCGGCTCTTCTT. The PCR
fragments obtained were linked to the T7 promoter and amplified again
by PCR. The T7-linked PCR products were used for transcription of single
stranded RNA and subsequently annealed with complementary RNA to
obtain double stranded RNA. As control RNAi, we used RNA duplex for
the Escherichia coli LacZ gene as provided by the manufacturer. The RNA
duplexes obtained were cleaved into 21–23 nucleotide fragments with
Dicer enzyme.
Transfection was performed using Lipofectamine-Plus Reagent (Invi-
trogen). A total of 1 or 4  g of plasmid DNA was used to transfect HeLa
cells in a well of a 6-well plate or a 10-cm dish, respectively. To transfect
siRNA into HeLa cells, we used Lipofectamine 2000 (Invitrogen). For immu-
nofluorescence, we used 0.3  g of siRNA together with 0.5  g of pEGFP-
histone H2B and 6  l of Lipofectamine 2000 diluted in Opti-MEM. The
mixture was added to one well of a 6-well plate and incubated for 2 h at
37 C with 5% CO2. For time-lapse imaging, the cells were transfected with
pEGFP-EB1 and pDsRed2-histone H2Bk, together with 0.3  g of siRNA for
either Ect2 or Cdc42 or both. The medium was replaced by DME contain-
ing 10% FCS and allowed to incubate for 48 h before observation.
Cell culture and synchronization
HeLa S3 cells were maintained in DME supplemented with 10% FCS and
antibiotics at 37 C and with 5% CO2. Cells were synchronized at early S
phase by the double thymidine block as described previously (Bostock et
al., 1971). In brief, cells were seeded at a density of 2   10
5 per dish
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DME containing 10 mM thymidine and 5% FCS, and the cells were incu-
bated for 12 h. The thymidine-containing medium was removed and the
cells were washed twice with PBS without divalent cations. The cells were
further cultured in DME containing 10% FCS for 10 h, and then subjected
to the second thymidine block for 12 h. The cells were washed twice with
PBS and placed in fresh DME containing 10% FCS. Cells were collected in
G2 phase, prometaphase, metaphase, telophase, and G1 phase as de-
scribed previously (Kimura et al., 2000). The cells were either frozen im-
mediately for pull-down assays or used for immunofluorescence. In overex-
pression experiments, we prolonged the time of the second thymidine
block to 15 h, during which we transfected cells using Lipofectamine Plus,
8 to 11 h after the addition of thymidine. For cell cycle analysis, we
cotransfected cells with siRNA and pEGFP-histone H2Bk, stained the cells
with propidium iodide, and subsequently examined the progression of
cells expressing EGFP-histone H2Bk by flow cytometry (Darzynkiewicz,
1994).
Pull-down assays
Recombinant GST-Pak-CRIB was prepared and conjugated with glu-
tathione-Sepharose 4B (Amersham Biosciences) as described previously
(Matsuo et al., 2002). Frozen HeLa S3 cells were suspended in the lysis
buffer containing 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM MgCl2,
1% NP-40, and 10% glycerol supplemented with 10 mM NaF, 1 mM
NaVO4, 100  g/ml PMSF, 5  g/ml leupeptin, and 5  g/ml pepstatin.
The cell suspension was incubated for 15 min at 4 C with continuous agita-
tion and centrifuged at 18,000 g for 15 min at 4 C. Supernatant was
saved and sonicated on ice for 1 s 10 times. Protein concentration was de-
termined by the Lowry method, and 800  g of the supernatant protein was
incubated with 40  g of GST-CRIB-Pak for 30 min at 4 C. The beads were
spun down and washed three times with the lysis buffer. One fourth or one
eighth of the precipitates were subjected to SDS-PAGE to determine the
amounts of GTP-Rac and GTP-Cdc42, respectively, and one twenty fifth of
the supernatant was used to determine the total amounts of Rac and
Cdc42. Separated proteins were transferred onto nitrocellulose membranes
(Schleicher & Schuell; BA 83). The membranes were blotted with antibod-
ies to Cdc42 (P-1) and Rac1. After the density of each band was deter-
mined, the amount of GTP-Cdc42 was calculated by (the density of each
GTP-Cdc42 band   8)/(the density of the total Cdc42 band in the G2
phase of each blot   25), and expressed as a percentage of the total
amount. The amount of GTP-Rac was calculated similarly. The pull-down as-
say for RhoA was performed as described previously (Kimura et al., 2000).
Time-lapse live imaging
HeLa cells were seeded on 35-mm glass-bottomed dishes (MatTek) and af-
ter overnight culture the cells were transfected with pEGFP-EB1 and
pDsRed2-histone H2Bk, together with siRNA of Ect2 or Cdc42 or both, as
described in the section Plasmids, siRNA preparation, and transfection.
After 48 h, the dish was placed on a temperature-controlled stage main-
tained at 37 C with 5% CO2. Live-imaging was performed on an inverted
microscope (model DMIRE2; Leica) with 63  NA 1.3 lenses equipped
with a high pressure lamp (Xenon). EGFP, DsRed, and brightfield images
were taken with a camera (model CoolSNAP HQ) driven by AS MDW
software (Leica). Sequential time-lapse images were acquired every 2.5
min for control RNAi or at 5-min intervals for Ect2 and Cdc42 RNAi. For
the cells shown in Fig. 4 (A and B), one Z section was recorded at each
time interval. For the cell shown in Fig. 4 C, a collection of 20 Z sections
at 0.5- m step intervals were acquired. The images obtained from Fig. 4
(B and C) were processed by deconvolution using a nonblind method and
analyzed with AS MDW and Deblur software (Leica).
Immunofluorescence
Cells collected at various times of mitosis were washed with PBS before
fixation with 3.7% PFA in PBS at 37 C for 15 min. The cells were washed
three times with PBS and permeabilized with 0.5% Triton X-100 in PBS for
5 min, followed by three washes with PBS. For kinetochore and Mad2
staining, the cells were preextracted with 0.5% Triton X-100 in PHEM
buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, and 1 mM Mg-ace-
tate, pH 6.9) for 1 min on ice just before fixation with 3.7% PFA in PBS
(Dujardin et al., 1998). After immersion in 100 mM glycine in PBS for 30
min, samples were incubated with 3% BSA in PBS for 30 min. The sam-
ples were incubated for 1 h at RT or 4 C overnight with indicated combi-
nations of the following primary antibodies: anti– -tubulin (1:200), anti-
Mad2 (Covance; 1:100), and CREST serum (1:500). After three washes
with PBS, the samples were incubated with appropriate secondary anti-
bodies coupled to Alexa Fluor 488, Alexa Fluor 594, or Alexa Fluor 647
(Molecular Probes) and DAPI (WAKO). The samples were washed three
times with PBS before mounting on glass slides. For detection of Cdc42,
cells on the coverslips were rinsed with PHEM solution and extracted with
0.5% Triton X-100 in PHEM for 1 min before fixation with 3.7% PFA in
PBS at RT. Antibodies to Cdc42 and MgcRacGAP were used at 1:200
and 1:1,000 dilution, respectively. Immunofluorescence for mDia3 has
been described previously (Yasuda et al., 2004).
For high-resolution imaging, fluorescence images were obtained
with a microscope (model IX70; Olympus) using oil immersion objective
lenses (PlanApo 60, NA 1.4; and PlanApo 100, NA 1.4) and high-selec-
tivity filters under the control of softWoRx software. Serial optical section
data (15–30 focal planes at 0.5- m intervals for 60  or 0.2- m intervals
for 100  objectives) were collected on a Peltier-cooled charge-coupled
device (Photometrics) and computationally processed by a three-dimen-
sional deconvolution method (Agard et al., 1989).
Online supplemental material
Fig. S1 shows the mitotic phenotype of HeLa cells expressing CRIB-
Pak. Videos 1–3 show mitosis of HeLa cells transfected with control
siRNA, Ect2 siRNA, and Cdc42 siRNA, respectively. Online supplemental
material is available at http://www.jcb.org/cgi/content/full/jcb.
200408085/DC1.
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